SCHEMBL22340950

SCHEMBL22340950

CCCC(C)N(Cc1ccc(F)cc1)c1ccc(OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPK1 P28482 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTT P42858 3/20 0.41
LMNA P02545 3/20 0.41
MITF O75030 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
GPR35 Q9HC97 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
XBP1 P17861 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.39
TACR1 P25103 1/20 0.39
APLNR P35414 3/20 0.38
S1PR1 P21453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20871412 0.93 HTT (0.42) MAPK1POLBL3MBTL1HTTCNR1
SCHEMBL29336140 0.89 MAPK1 (0.44) KMT2AMEN1MAPK1MAPTKDM4E
SCHEMBL20871164 0.88 CNR1 (0.45) KMT2AMEN1MAPTL3MBTL1HTT
SCHEMBL22340948 0.88 CNR1 (0.45) KMT2AMEN1MAPTL3MBTL1HTT
SCHEMBL22340961 0.86 APP (0.44) MAPK1L3MBTL1HTTCNR1CNR2
SCHEMBL22340951 0.86 BCL2A1 (0.47) KMT2AMEN1HTTLMNANPSR1
SCHEMBL29336228 0.86 KMT2A (0.41) KMT2AMEN1MAPK1MAPTL3MBTL1
SCHEMBL22340953 0.86 MEN1 (0.48) KMT2AMEN1HTTTAAR1SMN1; SMN2
SCHEMBL29335353 0.84 TAAR1 (0.51) KMT2AMEN1MAPK1MAPTKDM4E
SCHEMBL22340943 0.84 QPCT (0.45) KMT2AMEN1HTTAPLNRTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 KMT2A 1195/4885MEN1 134/4885MAPK1 2759/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A KMT2A 1042/4885MEN1 295/4885MAPK1 2759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.